November 2026

Smivet BV has gone through a very intense 10 month period in 2026 and is now happy to be able to announce big steps forward in the further development of its products in the pipeline. We are especially grateful to the investors interested in the Tetanus Antitoxin product for use in animals and humans. Their support will make it possible to abandon the use of horses in the process of harvesting serum and processing it into a Tetanus Antitoxin product, as done in the past century. Stay tuned!